Durant F - Search Results

1

3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonism.

Boulanger T, Vercauteren DP, Durant F, Andre JM. Boulanger T, et al. Among authors: durant f. J Theor Biol. 1987 Aug 21;127(4):479-89. doi: 10.1016/s0022-5193(87)80144-3. J Theor Biol. 1987. PMID: 2832660

2

Structure and molecular modeling of GABAA receptor antagonists.

Rognan D, Boulanger T, Hoffmann R, Vercauteren DP, Andre JM, Durant F, Wermuth CG. Rognan D, et al. Among authors: durant f. J Med Chem. 1992 May 29;35(11):1969-77. doi: 10.1021/jm00089a005. J Med Chem. 1992. PMID: 1317920

3

Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist.

Collin S, Evrard G, Vercauteren DP, Durant F, Carrupt PA, van de Waterbeemd H, Testa B. Collin S, et al. Among authors: durant f. J Med Chem. 1989 Jan;32(1):38-42. doi: 10.1021/jm00121a008. J Med Chem. 1989. PMID: 2521253

4

Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.

Wouters J, Moureau F, Vercauteren DP, Evrard G, Durant F, Koenig JJ, Ducrey F, Jarreau FX. Wouters J, et al. Among authors: durant f. J Neural Transm Suppl. 1994;41:313-9. doi: 10.1007/978-3-7091-9324-2_41. J Neural Transm Suppl. 1994. PMID: 7931244

5

Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands.

Collin S, Vercauteren DP, Vanderveken D, Evrard G, Durant F. Collin S, et al. Among authors: durant f. J Comput Aided Mol Des. 1989 Mar;3(1):39-53. doi: 10.1007/BF01590994. J Comput Aided Mol Des. 1989. PMID: 2715795

6

Synthesis and biochemical evaluation of baclofen analogues locked in the baclofen solid-state conformation.

Mann A, Boulanger T, Brandau B, Durant F, Evrard G, Heaulme M, Desaulles E, Wermuth CG. Mann A, et al. Among authors: durant f. J Med Chem. 1991 Apr;34(4):1307-13. doi: 10.1021/jm00108a011. J Med Chem. 1991. PMID: 1849996

7

Structure-affinity relationships of baclofen and 3-heteroaromatic analogues.

Pirard B, Carrupt PA, Testa B, Tsai RS, Berthelot P, Vaccher C, Debaert M, Durant F. Pirard B, et al. Among authors: durant f. Bioorg Med Chem. 1995 Nov;3(11):1537-45. doi: 10.1016/0968-0896(95)00144-6. Bioorg Med Chem. 1995. PMID: 8634834

8

Molecular modelling and conformational analysis of a GABAB antagonist.

Pirard B, Durant F. Pirard B, et al. Among authors: durant f. J Comput Aided Mol Des. 1996 Feb;10(1):31-40. doi: 10.1007/BF00124463. J Comput Aided Mol Des. 1996. PMID: 8786413

9

Molecular structure and stereoelectronic properties of sarmazenil--a weak inverse agonist at the omega modulatory sites (benzodiazepine receptors): comparison with bretazenil and flumazenil.

López-Romero B, Evrard G, Durant F, Sevrin M, George P. López-Romero B, et al. Among authors: durant f. Bioorg Med Chem. 1998 Oct;6(10):1745-57. doi: 10.1016/s0968-0896(98)00117-5. Bioorg Med Chem. 1998. PMID: 9839004

10

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Norberg B, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: durant f. Acta Crystallogr C. 2000 Oct;56 ( Pt 10):1265-6. doi: 10.1107/s0108270100009872. Acta Crystallogr C. 2000. PMID: 11025320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters